New Name for PCOS: Understanding Polyendocrine Metabolic Ovarian Syndrome
Introduction to the Name Change
A hormonal disorder that impacts 1 in 8 women globally has been rebranded to enhance treatment options. The condition, previously known as polycystic ovary syndrome (PCOS), is now referred to as polyendocrine metabolic ovarian syndrome. Advocates for this change argue that the former name oversimplified a complex endocrine disorder, leading to misunderstandings about cysts and a narrow focus on the ovaries, which has resulted in missed diagnoses and insufficient care, according to the Endocrine Society, a worldwide organization of medical professionals.
Dr. Melanie Cree, a pediatric endocrinologist at the University of Colorado Anschutz and co-author of a recent article in The Lancet, stated, "The previous terminology was misleading, as it suggested the presence of cysts in the ovaries, which is not always the case. The intention behind the new name is to foster improved care through a more accurate representation of the condition." This name change, the result of 14 years of collaboration among experts and patients, was officially announced in The Lancet on Tuesday.
Understanding PMOS
What is PMOS?
The newly named condition is characterized by hormonal fluctuations that can impact weight, metabolic health, mental well-being, reproductive functions, and skin conditions. It is linked to metabolic syndrome, a cluster of health issues that heightens the risk of Type 2 diabetes, heart disease, and stroke, as noted by Dr. Sarah Hutto from the University of Minnesota Medical School.
While the exact causes of PMOS remain unclear, factors such as genetics and obesity are believed to contribute, according to the Cleveland Clinic.
Symptoms of PMOS
Recognizing the Symptoms
Symptoms of PMOS can vary widely, complicating the diagnostic process. Common indicators include irregular menstrual cycles and elevated levels of androgens, which can lead to acne and abnormal hair growth or thinning. Although follicles may develop on the ovaries, they are not classified as cysts. For a diagnosis in adolescents, both irregular periods and signs of high androgen levels must be present, which may manifest as severe acne or excessive hair growth.
Impact on Fertility
PMOS and Infertility
Experts from the Cleveland Clinic identify PMOS as the leading cause of infertility in women, as infrequent ovulation can hinder conception. Additionally, those with PMOS may face increased risks of pregnancy complications, including gestational diabetes and preterm labor. However, many individuals with this condition can still have successful pregnancies.
Treatment Options for PMOS
Managing PMOS
According to Dr. Cree, the primary approach to treating PMOS involves lifestyle modifications, such as reducing processed food intake, engaging in regular exercise, and ensuring adequate sleep. "This is not about being judgmental; there is scientific evidence supporting these recommendations," she explained. Excess insulin levels in many women with PMOS can lead to increased testosterone production, which is responsible for various symptoms.
Other treatment options may include insulin-sensitizing medications like Metformin, androgen-blocking drugs, and hormonal contraceptives. Dr. Hutto emphasizes that treatment plans should be tailored to address individual symptoms and concerns, with those seeking pregnancy focusing on fertility treatments, while others may prefer hormonal birth control.
The Significance of the Name Change
Raising Awareness
Medical professionals are actively promoting the new name among their peers through conferences and medical societies, aiming to enhance understanding of the condition and improve patient care. Dr. Cree expressed her enthusiasm for the name change, stating, "I am thrilled about this development, and many of my colleagues share this excitement."